The Enterprise Value as of December 2025 (TTM) for Welgene Biotech Co.,Ltd. (6661.TWO) is 407.30M

According to Welgene Biotech Co.,Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 407.30M. This represents a change of -15.62% compared to the average of 482.71M of the last 4 quarters.

Welgene Biotech Co.,Ltd. (6661.TWO) Historical Enterprise Value (quarterly & annually)

How has 6661.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Welgene Biotech Co.,Ltd. over the last ten years is 435.29M. The current 407.30M Enterprise Value has changed 9.26% with respect to the historical average. Over the past ten years (40 quarters), 6661.TWO's Enterprise Value was at its highest in in the June 2024 quarter at 728.70M. The Enterprise Value was at its lowest in in the March 2016 quarter at 0.

Welgene Biotech Co.,Ltd. (6661.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Welgene Biotech Co.,Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Welgene Biotech Co.,Ltd. (6661.TWO) Average Enterprise Value

How has 6661.TWO Enterprise Value performed in the past?

The current Enterprise Value of Welgene Biotech Co.,Ltd. (6661.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Welgene Biotech Co.,Ltd. (6661.TWO) Enterprise Value vs. Peers

How is 6661.TWO’s Enterprise Value compared to its peers?

Welgene Biotech Co.,Ltd.’s Enterprise Value is less than Taiwan Advanced Nanotech Inc. (634.94M), greater than UniPharma Co., Ltd. (394.47M), greater than EPS Bio Technology Corp. (387.95M), less than DuoGenic StemCells corporation (680.91M), less than Sunder Biomedical Tech. Co., Ltd. (754.71M), less than Pharmigene, Inc. (1.11B), less than A-SPINE Asia Co., Ltd. (612.88M), less than Sofiva Genomics Co.,Ltd. (609.02M), less than Health & Life Co., Ltd. (546.95M), greater than Feng Chi Biotech Corp. (276.92M),

Build a custom stock screener for Welgene Biotech Co.,Ltd. (6661.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Welgene Biotech Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Welgene Biotech Co.,Ltd. (6661.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Welgene Biotech Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.